Trade PTI now with
12/17/2019 7:33:24 AM Proteostasis: Positive Phase 2 Topline Results From Proprietary CFTR Modulator Combinations In F508del Homozygous CF
12/11/2019 7:16:26 AM Proteostasis To Initiate Personalized Medicine-Based Clinical Trial In European CF Patients With Genotypes Ineligible
12/2/2019 7:06:22 AM Proteostasis Therapeutics Regains Compliance With Nasdaq Listing Standards
6/4/2019 7:08:54 AM Proteostasis Therapeutics Receives Orphan Drug Designation In EU For PTI-428 For Cystic Fibrosis
6/3/2019 7:08:21 AM Proteostasis Therapeutics Announces Presentations And Hosts Educational Symposium
3/25/2019 7:08:44 AM Proteostasis Therapeutics Announces Results From Phase 1 Clinical Studies Of Its Proprietary CFTR Modulators
2/6/2019 8:07:15 AM MJ Holdings Adds Emmanuel Dulac And Kim Cobleigh Drapkin To Board
12/17/2018 7:02:45 AM Proteostasis Therapeutics Unveils Global License Deal With Genentech
10/22/2018 4:13:06 PM Proteostasis Therapeutics Plans To Offer 9 Mln Common Shares In Public Offering
4/17/2018 7:14:14 AM Proteostasis Therapeutics Receives Endorsement From Cystic Fibrosis Foundation's Therapeutic Development Network
4/4/2018 6:02:07 AM Proteostasis Therapeutics Gets FDA Fast Track Designation For Triple Combination Program For Cystic Fibrosis